北美医疗器械测试市场，按服务类型（测试服务、检验服务和认证服务）、测试类型（物理测试、化学/生物测试、网络安全测试、微生物学和无菌测试等）、阶段（临床前和临床）、采购类型（内部和外包）、设备类别（I 类、II 类和 III 类）、产品（有源植入医疗器械、有源医疗器械、无源医疗器械、体外诊断医疗器械、眼科医疗器械、骨科和牙科医疗器械、血管医疗器械等）划分 - 行业趋势和预测到 2030 年。
北美医疗器械测试市场分析与洞察
医疗器械至关重要，因为它们直接影响人类生命。医疗器械制造商遵循测试、验证和确认最佳实践，以确保医疗器械的质量和可靠性，从而为患者提供安全有效的医疗服务。这里有一个关于实施医疗器械测试策略的高级概述。多个监管机构和合规机构管理医疗器械。另一方面，最终用户期望他们使用的设备具有卓越的性能、有效性和安全性。这迫使医疗器械制造商创建和部署适用于整个开发周期的测试策略 - 从概念和设计到生产。
全球对医疗器械验证和确认的需求不断增长，促进了市场的增长。在这一关键时期，一些主要市场参与者高度关注各种服务的推出和服务批准。此外，体外测试需求的增加也助长了医疗器械测试需求的增加。由于市场参与者的增加和先进服务的可用性，北美医疗器械测试市场在预测年将增长。
然而，医疗器械本地发展的障碍和医疗器械的高成本可能会阻碍预测期内北美医疗器械测试市场的增长。
Data Bridge Market Research分析，北美医疗器械测试市场预计到2030年将达到49.0416亿美元的价值，预测期内的复合年增长率为12.0%。
|
报告指标 |
细节 |
|
预测期 |
2023 至 2030 年 |
|
基准年 |
2022 |
|
历史岁月 |
2021 (可定制为 2015-2020) |
|
定量单位 |
收入（百万美元） |
|
涵盖的领域 |
服务类型（测试服务、检验服务和认证服务）、测试类型（物理测试、化学/生物测试、网络安全测试、微生物学测试和无菌测试等）、阶段（临床前和临床）、采购类型（内部和外包）、设备类别（I 类、II 类和 III 类）、产品（有源植入医疗器械、有源医疗器械、无源医疗器械、体外诊断医疗器械、眼科医疗器械、骨科和牙科医疗器械、血管医疗器械等） |
|
覆盖国家 |
美国、加拿大和墨西哥 |
|
涵盖的市场参与者 |
Intertek Group plc、SGS SA、Bureau Veritas、TUV SUD、TUV Rheinland、Pace、Charles River Laboratories.、Biomedical Device Labs、UL LLC、North American Science Associates, LLC、WuXi AppTec、NSF.、Laboratory Corporation of America Holdings、Eurofins Scientific、NELSON LABORATORIES, LLC- A SOTERA HEALTH COMPANY、Gateway Analytical.、Element Materials Technology、Hohenstein、Cigniti、Q Laboratories 和 IMR Test Labs 等 |
市场定义
医疗器械测试是证明设备在使用过程中可靠且安全的过程。在新产品开发中，会应用广泛的设计验证测试。这包括性能测试、毒性、化学分析，有时还包括人为因素甚至临床测试。持续的质量保证测试通常更为有限。这通常包括尺寸检查、一些功能测试和包装验证。市场上有各种类型的医疗测试服务，例如检验服务、认证服务等。
北美医疗器械测试市场动态
本节旨在了解市场驱动因素、优势、机遇、限制和挑战。下面将详细讨论所有这些内容：
驱动程序
- 医疗器械验证需求日益增长
医疗器械测试是证明设备能够可靠、安全地进行诊断和治疗的过程。由于全球各个地区各种疾病的发病率很高，对医疗器械的需求不断上升。
验证和确认方法在医疗保健行业中广泛使用。一般来说，验证是产品开发阶段的一项工作，用于检查产品是否符合指定要求，而确认则用于检查产品是否符合预期用途，从而满足可用性要求。医疗器械最常见的验证和确认类型是设计、流程和软件验证和确认。
医疗器械也因采用先进的工程塑料而变得更小、设计更复杂。这使得验证和确认 (V&V) 过程变得更加重要。其结果是可重复性更好、错误更少、返工和重新设计更少、上市时间更快、竞争力更强、生产成本更低。此外，有关医疗器械验证和确认服务的标准和法规日益增多，预计将推动医疗器械测试市场的增长。
- 体外测试需求不断增长
体外诊断 (IVD) 是对从人体采集的血液或组织等样本进行的测试。体外诊断可以检测疾病或其他状况，并可用于监测一个人的整体健康状况，以帮助治愈、治疗或预防疾病。
体外测试用于各种疾病检测，例如艾滋病毒感染、疟疾和肝炎等。此类疾病的流行率在全球范围内迅速上升，导致对体外测试和各种医疗设备的需求不断增加。由于医疗测试公司快速制造，各种疾病的医疗设备已广泛可用，这是推动市场增长的主要因素。
机会
- 医疗支出增加
随着各国可支配收入的增加，全球医疗支出也随之增加。此外，为了满足人口需求，政府机构和医疗组织正在积极加快医疗支出。医疗支出的增加同时有助于医疗机构改善各国针对各种疾病的治疗设施。
医疗支出的增长也有利于进一步的经济增长和医疗保健行业的增长，而且它主要是富有成效的，因为它显著影响了更好、更先进的医疗产品的开发。因此，医疗支出的激增为北美医疗器械测试市场的增长提供了更大的机会。
- 各种医疗设备中人工智能和物联网的发展
人工智能(AI) 是一项强大且不断涌现的技术，它有潜力提高众多行业的能力。配备人工智能的医疗设备有望彻底改变医疗保健行业，帮助医疗专业人员更准确、更有效地诊断和治疗患者，并改善他们的整体护理。除了其好处之外，医疗设备人工智能也面临挑战，包括需要监管以跟上技术进步的步伐。
因此，北美医疗器械测试市场正在见证药物-设备组合、个性化医疗以及各种便携式和可穿戴医疗器械的升级适应性等一系列发展。在各种设备中实施物联网和人工智能等技术进步是全球医疗器械测试服务市场的一个关键增长参数，创造了巨大的机会。
挑战/限制
- 医疗技术行业竞争激烈
许多全球公司都面临着来自许多公司的激烈竞争，这些公司包括拥有多条产品线的大型医疗器械制造公司。一些参与者比其他参与者拥有更广泛的财务和营销资源。医疗保健领域的共同竞争涉及价格、质量、便利性和品牌等各种因素。竞争也可以基于新技术和创新。一般来说，竞争可以减少效率低下，否则会产生高昂的产出成本，而这些成本最终会通过高昂的医疗保健和交付成本转嫁给消费者。市场上的产品是根据产品规格、产品一致性、供应和价格进行营销的。然而，消费者从竞争中受益，竞争为持续的产品升级提供了奖励，并促进了行业参与者提高服务效率。公司在市场上的竞争力也受到消费者偏好和要求变化的影响，例如对更环保的医疗器械的需求不断增长，这些医疗器械可以轻松丢弃而不会损害环境，并且产品具有数字功能。这表明市场竞争激烈，这对市场来说是一个重大挑战。
- 医疗器械本土发展的障碍
虽然促进医疗器械的标准和控制至关重要，但过度的监管，特别是在国内背景下，也会成为这些器械本地创新的障碍。
新技术的许可程序冗长且昂贵，这可能会阻碍国内创新，从而增加当地制造商在医疗设备制造成本之外所花费的成本和时间。一些对低收入国家来说具有重要价值的产品可能会因使用时存在风险而被从市场上撤下。
当地开发制造商面临的许可程序、医疗设备成本以及生产医疗器械的各种其他法规等各种因素都可能阻碍医疗器械测试市场的增长。
最新动态
- 2021 年 4 月，TÜV SÜD 宣布已在 Medtec LIVE 上亮相，展示其作为医疗器械测试一站式服务商的能力。该公司的服务涵盖电气和功能安全、网络安全和软件、EMC 和生物相容性测试。TÜV SÜD 的专家在在线贸易展和大会的节目中进行了各种演讲、现场直播和电梯演讲。
- 2020 年 6 月，Intertek 宣布扩大其个人防护设备服务，包括根据美国国家职业安全与健康研究所 (NIOSH) 的要求对 N95 口罩进行预认证测试。新服务是根据 ISO 17025 成功获得 NIOSH 标准测试协议认证的结果。借助这些新服务，Intertek 扩展了其解决方案和资源，以在 COVID-19 疫情期间为客户和全球社区提供支持。
北美医疗器械测试市场范围
北美医疗器械测试市场分为服务类型、测试类型、阶段、采购类型、设备类别和产品。细分市场之间的增长有助于您分析利基增长领域和进入市场的策略，并确定您的核心应用领域和目标市场的差异。
服务类型
- 测试服务
- 检验服务
- 认证服务
根据服务类型，北美医疗器械测试市场分为测试服务、检验服务和认证服务。
测试类型
- 物理测试
- 化学/生物测试
- 网络安全测试
- 微生物学和无菌测试
- 其他的
根据测试类型，北美医疗器械测试市场分为物理测试、化学/生物测试、网络安全测试、微生物学和无菌测试等。
阶段
- 临床前
- 临床
根据阶段，北美医疗器械测试市场分为临床前和临床。
采购类型
- 内部
- 外包
根据采购类型，北美医疗器械测试市场分为内部和外包
设备类别
- 一级
- II 类
- III 级
根据设备类别，北美医疗器械测试市场分为 I 类、II 类和 III 类。
产品
- 有源植入医疗器械
- 有源医疗器械
- 无源医疗器械
- 体外诊断医疗器械
- 眼科医疗器械
- 骨科及牙科医疗器械
- 血管医疗器械
- 其他的
根据产品，北美医疗器械测试市场细分为有源植入医疗器械、有源医疗器械、无源医疗器械、体外诊断医疗器械、眼科医疗器械、骨科和牙科医疗器械、血管医疗器械等。
北美医疗器械测试市场区域分析/见解
北美医疗器械测试市场分为服务类型、测试类型、阶段、采购类型、设备类别和产品。
本市场报告涵盖的国家包括美国、加拿大和墨西哥。
由于该地区医疗器械测试的普及率高且医疗保健支出不断增长，预计美国将主导市场。
报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和国内市场监管变化。新销售、替代销售、国家人口统计、监管法案和进出口关税等数据点是用于预测各个国家市场情景的一些主要指标。此外，在对国家数据进行预测分析时，还考虑了欧洲品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战，以及销售渠道的影响。
竞争格局和北美医疗器械测试市场份额分析
北美医疗器械测试市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、生产基地和设施、公司优势和劣势、产品发布、产品试验渠道、产品批准、专利、产品宽度和广度、应用优势、技术生命线曲线。以上提供的数据点仅与公司对北美医疗器械测试市场的关注有关。
北美医疗器械测试市场的一些主要参与者包括 Intertek Group plc、SGS SA、Bureau Veritas、TUV SUD、TUV Rheinland、Pace、Charles River Laboratories.、Biomedical Device Labs、UL LLC、North American Science Associates, LLC、WuXi AppTec、NSF.、Laboratory Corporation of America Holdings、Eurofins Scientific、NELSON LABORATORIES, LLC- A SOTERA HEALTH COMPANY、Gateway Analytical.、Element Materials Technology、Hohenstein、Cigniti、Q Laboratories 和 IMR Test Labs 等。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA MEDICAL DEVICE TESTING MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 SERVICE TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET TESTING TYPE COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER'S FIVE FORCES
5 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: REGULATIONS
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 RISING NEED FOR VERIFICATION VALIDATION OF MEDICAL DEVICES
6.1.2 INCREASING DEMAND FOR IN-VITRO TESTS
6.1.3 ESCALATION IN INNOVATION AND TECHNOLOGIES
6.2 RESTRAINTS
6.2.1 BARRIERS TO THE LOCAL DEVELOPMENT OF MEDICAL DEVICES
6.2.2 HIGH COST OF MEDICAL DEVICES
6.3 OPPORTUNITIES
6.3.1 RISE IN HEALTHCARE EXPENDITURE
6.3.2 DEVELOPMENT IN AI AND IOT IN VARIOUS MEDICAL DEVICES
6.3.3 STRATEGIC INITIATIVES OF KEY PLAYERS
6.4 CHALLENGES
6.4.1 HIGH COMPETITION IN MEDICAL TECHNOLOGY INDUSTRY
6.4.2 LONG LEAD TIME FOR OVERSEAS QUALIFICATION
7 NORTH AMERICA MEDICAL DEVICE TESTING MARKET, BY SERVICE TYPE
7.1 OVERVIEW
7.2 TESTING SERVICES
7.3 INSPECTION SERVICES
7.4 CERTIFICATION SERVICES
8 NORTH AMERICA MEDICAL DEVICE TESTING MARKET, BY TESTING TYPE
8.1 OVERVIEW
8.2 CHEMICAL/BIOLOGICAL TESTING
8.3 MICROBIOLOGY AND STERILITY TESTING
8.3.1 STERILITY TEST & VALIDATION
8.3.2 BIO BURDEN DETERMINATION
8.3.3 ANTIMICROBIAL ACTIVITY TESTING
8.3.4 PYROGEN & ENDOTOXIN TESTING
8.3.5 OTHERS
8.4 PHYSICAL TESTING
8.4.1 ELECTRICAL SAFETY TESTING
8.4.2 FUNCTIONAL SAFETY TESTING
8.4.3 EMC TESTING
8.4.4 ENVIRONMENTAL TESTING
8.4.5 OTHERS
8.5 CYBERSECURITY TESTING
8.6 OTHERS
9 NORTH AMERICA MEDICAL DEVICE TESTING MARKET, BY PHASE
9.1 OVERVIEW
9.2 PRECLINICAL
9.3 CLINICAL
10 NORTH AMERICA MEDICAL DEVICE TESTING MARKET, BY SOURCING TYPE
10.1 OVERVIEW
10.2 OUTSOURCED
10.3 IN-HOUSE
11 NORTH AMERICA MEDICAL DEVICE TESTING MARKET, BY DEVICE CLASS
11.1 OVERVIEW
11.2 CLASS I
11.3 CLASS III
11.4 CLASS II
12 NORTH AMERICA MEDICAL DEVICE TESTING MARKET, BY PRODUCT
12.1 OVERVIEW
12.2 NON-ACTIVE MEDICAL DEVICE
12.3 ORTHOPEDIC AND DENTAL MEDICAL DEVICE
12.4 ACTIVE IMPLANT MEDICAL DEVICE
12.5 VASCULAR MEDICAL DEVICE
12.6 ACTIVE MEDICAL DEVICE
12.7 IN-VITRO DIAGNOSTICS MEDICAL DEVICE
12.8 OPTHALMIC MEDICAL DEVICE
12.9 OTHERS
13 NORTH AMERICA MEDICAL DEVICE TESTING MARKET, BY GEOGRAPHY
13.1 NORTH AMERICA
13.1.1 U.S.
13.1.2 CANADA
13.1.3 MEXICO
14 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
15 SWOT ANALYSIS
16 COMPANY PROFILE
16.1 LABORATORY CORPORATION OF AMERICA HOLDINGS
16.1.1 COMPANY SNAPSHOT
16.1.2 REVENUE ANALYSIS
16.1.3 COMPANY SHARE ANALYSIS
16.1.4 PRODUCT PORTFOLIO
16.1.5 RECENT DEVELOPMENTS
16.2 CHARLES RIVER LABORATORIES.
16.2.1 COMPANY SNAPSHOT
16.2.2 REVENUE ANALYSIS
16.2.3 COMPANY SHARE ANALYSIS
16.2.4 PRODUCT PORTFOLIO
16.2.5 RECENT DEVELOPMENTS
16.3 TUV SUD
16.3.1 COMPANY SNAPSHOT
16.3.2 REVENUE ANALYSIS
16.3.3 COMPANY SHARE ANALYSIS
16.3.4 PRODUCT PORTFOLIO
16.3.5 RECENT DEVELOPMENTS
16.4 WUXI APPTEC
16.4.1 COMPANY SNAPSHOT
16.4.2 REVENUE ANALYSIS
16.4.3 COMPANY SHARE ANALYSIS
16.4.4 PRODUCT PORTFOLIO
16.4.5 RECENT DEVELOPMENTS
16.5 SGS SA
16.5.1 COMPANY SNAPSHOT
16.5.2 REVENUE ANALYSIS
16.5.3 COMPANY SHARE ANALYSIS
16.5.4 PRODUCT PORTFOLIO
16.5.5 RECENT DEVELOPMENTS
16.6 NORTH AMERICAN SCIENCE ASSOCIATES, LLC
16.6.1 COMPANY SNAPSHOT
16.6.2 PRODUCT PORTFOLIO
16.6.3 RECENT DEVELOPMENTS
16.7 HOHENSTEIN
16.7.1 COMPANY SNAPSHOT
16.7.2 PRODUCT PORTFOLIO
16.7.3 RECENT DEVELOPMENTS
16.8 BIOMEDICAL DEVICE LABS
16.8.1 COMPANY SNAPSHOT
16.8.2 PRODUCT PORTFOLIO
16.8.3 RECENT DEVELOPMENTS
16.9 BUREAU VERITAS
16.9.1 COMPANY SNAPSHOT
16.9.2 REVENUE ANALYSIS
16.9.3 PRODUCT PORTFOLIO
16.9.4 RECENT DEVELOPMENTS
16.1 CIGNITI
16.10.1 COMPANY SNAPSHOT
16.10.2 REVENUE ANALYSIS
16.10.3 PRODUCT PORTFOLIO
16.10.4 RECENT DEVELOPMENTS
16.11 ELEMENT MATERIALS TECHNOLOGY
16.11.1 COMPANY SNAPSHOT
16.11.2 PRODUCT PORTFOLIO
16.11.3 RECENT DEVELOPMENTS
16.12 EUROFINS SCIENTIFIC
16.12.1 COMPANY SNAPSHOT
16.12.2 REVENUE ANALYSIS
16.12.3 PRODUCT PORTFOLIO
16.12.4 RECENT DEVELOPMENTS
16.13 GATEWAY ANALYTICAL.
16.13.1 COMPANY SNAPSHOT
16.13.2 PRODUCT PORTFOLIO
16.13.3 RECENT DEVELOPMENTS
16.14 IMR TEST LABS
16.14.1 COMPANY SNAPSHOT
16.14.2 PRODUCT PORTFOLIO
16.14.3 RECENT DEVELOPMENTS
16.15 INTERTEK GROUP PLC
16.15.1 COMPANY SNAPSHOT
16.15.2 REVENUE ANALYSIS
16.15.3 PRODUCT PORTFOLIO
16.15.4 RECENT DEVELOPMENTS
16.16 NELSON LABORATORIES, LLC- A SOTERA HEALTH COMPANY
16.16.1 COMPANY SNAPSHOT
16.16.2 PRODUCT PORTFOLIO
16.16.3 RECENT DEVELOPMENTS
16.17 NSF.
16.17.1 COMPANY SNAPSHOT
16.17.2 PRODUCT PORTFOLIO
16.17.3 RECENT DEVELOPMENTS
16.18 PACE
16.18.1 COMPANY SNAPSHOT
16.18.2 PRODUCT PORTFOLIO
16.18.3 RECENT DEVELOPMENTS
16.19 Q LABORATORIES
16.19.1 COMPANY SNAPSHOT
16.19.2 PRODUCT PORTFOLIO
16.19.3 RECENT DEVELOPMENTS
16.2 TUV RHEINLAND
16.20.1 COMPANY SNAPSHOT
16.20.2 REVENUE ANALYSIS
16.20.3 PRODUCT PORTFOLIO
16.20.4 RECENT DEVELOPMENTS
16.21 UL LLC
16.21.1 COMPANY SNAPSHOT
16.21.2 PRODUCT PORTFOLIO
16.21.3 RECENT DEVELOPMENTS
17 QUESTIONNAIRE
18 RELATED REPORTS
表格列表
TABLE 1 FDA REGULATIONS BASED ON DEVICES TYPE
TABLE 2 PRICES OF ESSENTIAL MEDICAL DEVICES
TABLE 3 NORTH AMERICA MEDICAL DEVICE TESTING MARKET, BY SERVICE TYPE, 2021-2030 (USD MILLION)
TABLE 4 NORTH AMERICA MEDICAL DEVICE TESTING MARKET, BY TESTING TYPE, 2021-2030 (USD MILLION)
TABLE 5 NORTH AMERICA MICROBIOLOGY AND STERILITY TESTING IN MEDICAL DEVICE TESTING MARKET, BY TESTING TYPE, 2021-2030 (USD MILLION)
TABLE 6 NORTH AMERICA PHYSICAL TESTING IN MEDICAL DEVICE TESTING MARKET, BY TESTING TYPE, 2021-2030 (USD MILLION)
TABLE 7 NORTH AMERICA MEDICAL DEVICE TESTING MARKET, BY PHASE, 2021-2030 (USD MILLION)
TABLE 8 NORTH AMERICA MEDICAL DEVICE TESTING MARKET, BY SOURCING TYPE, 2021-2030 (USD MILLION)
TABLE 9 NORTH AMERICA MEDICAL DEVICE TESTING MARKET, BY DEVICE CLASS, 2021-2030 (USD MILLION)
TABLE 10 NORTH AMERICA MEDICAL DEVICE TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 11 NORTH AMERICA MEDICAL DEVICE TESTING MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 12 U.S. MEDICAL DEVICE TESTING MARKET, BY SERVICE TYPE, 2021-2030 (USD MILLION)
TABLE 13 U.S. MEDICAL DEVICE TESTING MARKET, BY TESTING TYPE, 2021-2030 (USD MILLION)
TABLE 14 U.S. MICROBIOLOGY AND STERILITY TESTING IN MEDICAL DEVICE TESTING MARKET, BY TESTING TYPE, 2021-2030 (USD MILLION)
TABLE 15 U.S. PHYSICAL TESTING IN MEDICAL DEVICE TESTING MARKET, BY TESTING TYPE, 2021-2030 (USD MILLION)
TABLE 16 U.S. MEDICAL DEVICE TESTING MARKET, BY PHASE, 2021-2030 (USD MILLION)
TABLE 17 U.S. MEDICAL DEVICE TESTING MARKET, BY SOURCING TYPE, 2021-2030 (USD MILLION)
TABLE 18 U.S. MEDICAL DEVICE TESTING MARKET, BY DEVICE CLASS, 2021-2030 (USD MILLION)
TABLE 19 U.S. MEDICAL DEVICE TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 20 CANADA MEDICAL DEVICE TESTING MARKET, BY SERVICE TYPE, 2021-2030 (USD MILLION)
TABLE 21 CANADA MEDICAL DEVICE TESTING MARKET, BY TESTING TYPE, 2021-2030 (USD MILLION)
TABLE 22 CANADA MICROBIOLOGY AND STERILITY TESTING IN MEDICAL DEVICE TESTING MARKET, BY TESTING TYPE, 2021-2030 (USD MILLION)
TABLE 23 CANADA PHYSICAL TESTING IN MEDICAL DEVICE TESTING MARKET, BY TESTING TYPE, 2021-2030 (USD MILLION)
TABLE 24 CANADA MEDICAL DEVICE TESTING MARKET, BY PHASE, 2021-2030 (USD MILLION)
TABLE 25 CANADA MEDICAL DEVICE TESTING MARKET, BY SOURCING TYPE, 2021-2030 (USD MILLION)
TABLE 26 CANADA MEDICAL DEVICE TESTING MARKET, BY DEVICE CLASS, 2021-2030 (USD MILLION)
TABLE 27 CANADA MEDICAL DEVICE TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 28 MEXICO MEDICAL DEVICE TESTING MARKET, BY SERVICE TYPE, 2021-2030 (USD MILLION)
TABLE 29 MEXICO MEDICAL DEVICE TESTING MARKET, BY TESTING TYPE, 2021-2030 (USD MILLION)
TABLE 30 MEXICO MICROBIOLOGY AND STERILITY TESTING IN MEDICAL DEVICE TESTING MARKET, BY TESTING TYPE, 2021-2030 (USD MILLION)
TABLE 31 MEXICO PHYSICAL TESTING IN MEDICAL DEVICE TESTING MARKET, BY TESTING TYPE, 2021-2030 (USD MILLION)
TABLE 32 MEXICO MEDICAL DEVICE TESTING MARKET, BY PHASE, 2021-2030 (USD MILLION)
TABLE 33 MEXICO MEDICAL DEVICE TESTING MARKET, BY SOURCING TYPE, 2021-2030 (USD MILLION)
TABLE 34 MEXICO MEDICAL DEVICE TESTING MARKET, BY DEVICE CLASS, 2021-2030 (USD MILLION)
TABLE 35 MEXICO MEDICAL DEVICE TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
图片列表
FIGURE 1 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: DBMR MARKET POSITION GRID
FIGURE 8 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: MARKET TESTING TYPE COVERAGE GRID
FIGURE 9 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: SEGMENTATION
FIGURE 11 INCREASING DEMAND FOR IN-VITRO TESTS AND DEVELOPMENT IN AI AND IOT IN VARIOUS MEDICAL DEVICES ARE EXPECTED TO DRIVE THE NORTH AMERICA MEDICAL DEVICE TESTING MARKET IN THE FORECAST PERIOD OF 2023 TO 2030
FIGURE 12 TESTING SERVICES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA MEDICAL DEVICE TESTING MARKET IN 2023 & 2030
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF GLOBAL MEDICAL DEVICE TESTING MARKET
FIGURE 14 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY SERVICE TYPE, 2022
FIGURE 15 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY SERVICE TYPE, 2023-2030 (USD MILLION)
FIGURE 16 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY SERVICE TYPE, CAGR (2023-2030)
FIGURE 17 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY SERVICE TYPE, LIFELINE CURVE
FIGURE 18 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY TESTING TYPE, 2022
FIGURE 19 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY TESTING TYPE, 2023-2030 (USD MILLION)
FIGURE 20 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY TESTING TYPE, CAGR (2023-2030)
FIGURE 21 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY TESTING TYPE, LIFELINE CURVE
FIGURE 22 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY PHASE, 2022
FIGURE 23 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY PHASE, 2023-2030 (USD MILLION)
FIGURE 24 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY PHASE, CAGR (2023-2030)
FIGURE 25 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY PHASE, LIFELINE CURVE
FIGURE 26 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY SOURCING TYPE, 2022
FIGURE 27 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY SOURCING TYPE, 2023-2030 (USD MILLION)
FIGURE 28 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY SOURCING TYPE, CAGR (2023-2030)
FIGURE 29 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY SOURCING TYPE, LIFELINE CURVE
FIGURE 30 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY DEVICE CLASS, 2022
FIGURE 31 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY DEVICE CLASS, 2023-2030 (USD MILLION)
FIGURE 32 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY DEVICE CLASS, CAGR (2023-2030)
FIGURE 33 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY DEVICE CLASS, LIFELINE CURVE
FIGURE 34 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY PRODUCT, 2022
FIGURE 35 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY PRODUCT, 2023-2030 (USD MILLION)
FIGURE 36 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY PRODUCT, CAGR (2023-2030)
FIGURE 37 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 38 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: SNAPSHOT (2022)
FIGURE 39 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY COUNTRY (2022)
FIGURE 40 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY COUNTRY (2023 & 2030)
FIGURE 41 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY COUNTRY (2023 & 2030)
FIGURE 42 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY SERVICE TYPE (2023-2030)
FIGURE 43 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: COMPANY SHARE 2022 (%)
研究方法
数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。该阶段包括通过各种来源和策略获取市场信息或相关数据。它包括提前检查和规划从过去获得的所有数据。它同样包括检查不同信息源中出现的信息不一致。使用市场统计和连贯模型分析和估计市场数据。此外，市场份额分析和关键趋势分析是市场报告中的主要成功因素。要了解更多信息，请请求分析师致电或下拉您的询问。
DBMR 研究团队使用的关键研究方法是数据三角测量，其中包括数据挖掘、数据变量对市场影响的分析和主要（行业专家）验证。数据模型包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、专利分析、定价分析、公司市场份额分析、测量标准、全球与区域和供应商份额分析。要了解有关研究方法的更多信息，请向我们的行业专家咨询。
可定制
Data Bridge Market Research 是高级形成性研究领域的领导者。我们为向现有和新客户提供符合其目标的数据和分析而感到自豪。报告可定制，包括目标品牌的价格趋势分析、了解其他国家的市场（索取国家列表）、临床试验结果数据、文献综述、翻新市场和产品基础分析。目标竞争对手的市场分析可以从基于技术的分析到市场组合策略进行分析。我们可以按照您所需的格式和数据样式添加您需要的任意数量的竞争对手数据。我们的分析师团队还可以为您提供原始 Excel 文件数据透视表（事实手册）中的数据，或者可以帮助您根据报告中的数据集创建演示文稿。
